New PI may offer hope to triple class patients.
D017322:Clinical Trials, Phase II as Topic; D000069454:Darunavir; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013449:Sulfonamides / Q000627:therapeutic use*
D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D000069454:Darunavir